Bridgeline Digital (BLIN) 1.10 $BLIN Global Software and

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Bridgeline Digital (BLIN) 1.10 $BLIN

Global Software and Services Company Selects Bridgeline's iAPPS to Power Online Learning System
GlobeNewswire - Mon Jun 20, 10:47AM CDT
Bridgeline Digital, Inc. (NASDAQ:BLIN) announced today that a global software and services company targeting the healthcare, legal and finance space selected the iAPPS Digital Engagement Platform to power its law and business education system. By leveraging iAPPS, the company will provide personalized education tracks for legal and business professionals.
BLIN: 1.10 (-0.05)

These Small Cap Stocks Deserve Some Extra Attention Today, Here's Why!
ACCESSWIRE - Thu Jun 09, 8:15AM CDT
NEW YORK, NY / ACCESSWIRE / June 9, 2016 / The markets have been benefiting from a strong uptrend in recent trading and the following companies have demonstrated strong growth and momentum throughout.
BLIN: 1.10 (-0.05)

Bridgeline Digital Sets Eyes on Mid-Market Expansion with iAPPS Pro
GlobeNewswire - Wed Jun 08, 7:00AM CDT
Bridgeline Digital Inc. (NASDAQ:BLIN) announced today the launch of their new iAPPS Pro product line, a Web Experience Management System catering to the mid-market and nimble enterprise companies. The SaaS-based solution offers fully integrated marketing automation, web content management and eCommerce capabilities for companies and retailers.
BLIN: 1.10 (-0.05)

Bridgeline Digital to Present at Marcum MicroCap Conference
GlobeNewswire - Wed May 25, 7:00AM CDT
Bridgeline Digital, Inc. (NASDAQ:BLIN), developer of the award-winning iAPPS Web Engagement Management platform, announced today that Bridgeline Digital's CEO Ari Kahn and CFO Michael Prinn will be presenting on behalf of the company at the fifth annual Marcum MicroCap Conference to be held in New York, NY on Wednesday June 1 and Thursday June 2, 2016.
BLIN: 1.10 (-0.05)

Bridgeline Digital Announces Second Quarter and First Six Months of Fiscal 2016 Financial Results
GlobeNewswire - Thu May 12, 3:01PM CDT
Company Reports Positive Adjusted EBITDA for the Third Consecutive Quarter
BLIN: 1.10 (-0.05)

Bridgeline Digital Board Names Ari Kahn as Next CEO
GlobeNewswire - Thu May 12, 7:00AM CDT
Bridgeline Digital, Inc. (NASDAQ:BLIN), The Digital Engagement Company(TM), today announced that Ari Kahn, currently Bridgeline Digital's Chief Operating Officer and Interim Chief Executive Officer has been selected as Bridgeline Digital's new Chief Executive Officer. Kahn will assume the role effective immediately.
BLIN: 1.10 (-0.05)

Bridgeline Digital to Present at Taglich Brothers Annual Investment Conference
GlobeNewswire - Tue May 03, 10:02AM CDT
Bridgeline Digital, Inc. (NASDAQ:BLIN) announced today that Bridgeline's COO Ari Kahn and CFO Michael Prinn will be presenting on behalf of the company at the Taglich Brothers 13 Annual Investment Conference to be held in New York, NY on Tuesday May 3, 2016.
BLIN: 1.10 (-0.05)

Jerrick Media (JMDA) to Launch Cannabis Vertical in June 2016
ACCESSWIRE - Wed Apr 27, 8:25AM CDT
SEATTLE, WA / ACCESSWIRE / April 27, 2016 / Jerrick Media Holdings Inc. (OTCQB: JMDA), a digital media and technology company focused on branded digital content and e-commerce, recently announced the planned launch of Potent.Media in June of this year as its initial foray into the burgeoning cannabis industry.
BLIN: 1.10 (-0.05), MARK: 4.43 (+0.04), BVSN: 6.62 (+0.02), EVDY: 8.02 (+0.25)

Bridgeline Digital Announces ESL Credit Union Wins Multiple Industry Awards
GlobeNewswire - Tue Apr 05, 7:00AM CDT
Bridgeline Digital, Inc. (NASDAQ:BLIN), today announced that New York-based ESL Federal Credit Union has received three industry awards for its website ESL.org built on the iAPPS Digital Engagement Platform.
BLIN: 1.10 (-0.05)

American Insurance Association Launches Redesigned Site on iAPPS
GlobeNewswire - Wed Mar 23, 7:00AM CDT
Bridgeline Digital, Inc. (NASDAQ:BLIN), The Digital Engagement Company(TM), announced today the American Insurance Association (AIA) launched their redesigned website on the iAPPS Digital Engagement Platform.
BLIN: 1.10 (-0.05)

CIO Review Selects iAPPS as One of the 20 Most Promising Digital Marketing Solution Providers
GlobeNewswire - Wed Mar 16, 7:00AM CDT
Bridgeline Digital, Inc. (NASDAQ:BLIN), The Digital Engagement Company(TM), announced today that it was recently recognized as one of the 20 most promising digital marketing solution providers by CIO Review.
BLIN: 1.10 (-0.05)

YSI, a Xylem Brand, Recognized for Innovative Website
GlobeNewswire - Tue Mar 08, 7:00AM CST
Using iAPPS as the Backbone, the New YSI.com Seen As Leader in Biotechnology Space
BLIN: 1.10 (-0.05)

New Strong Buy Stocks for February 19th
Zacks Equity Research - Zacks Investment Research - Fri Feb 19, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
BLIN: 1.10 (-0.05), AMBR: 7.71 (+0.23), ADHD: 4.10 (-0.09), CPB: 62.64 (+0.05), BCO: 29.20 (+0.76)

Multi-Billion Dollar Manufacturing Company Selects Bridgeline Digital
GlobeNewswire - Fri Feb 19, 7:00AM CST
Bridgeline Digital, Inc. (NASDAQ:BLIN), The Digital Engagement Company(TM), announced today that a multi-billion dollar manufacturing company has selected Bridgeline Digital to help form the strategy for their new web presence.
BLIN: 1.10 (-0.05)

Bridgeline Digital's Accelerators Bear Fruit
GlobeNewswire - Wed Feb 10, 7:00AM CST
Bridgeline Digital, Inc. (NASDAQ:BLIN), today announced two customers have selected the new iAPPS accelerators to help them quickly launch rich digital experiences.
BLIN: 1.10 (-0.05)

Bridgeline Digital to Report Financial Results for the First Quarter of Fiscal 2016
GlobeNewswire - Fri Feb 05, 2:58PM CST
Bridgeline Digital, Inc. (NASDAQ:BLIN), The Digital Engagement Company(TM), announced today that it will release its financial results for the first quarter ended December 31, 2015 on Thursday, February 11, 2016 at 4:30 pm ET. On that day, Ari Kahn, the Company's Chief Operating Officer and Michael Prinn, the Company's Chief Financial Officer, plan to host a live conference call at 4:30 p.m. ET to discuss the financial results. A replay will be available for one week following the live call.
BLIN: 1.10 (-0.05)

GoPro Dives; 4 Small-Cap Growths Picks to Buy Instead
Zacks Equity Research - Zacks Investment Research - Thu Jan 14, 1:22PM CST
With GoPro plummeting, we present 4 top-ranked stocks from the small-cap universe that are strongly positioned for growth.
JAGX: 1.99 (+0.19), GPRO: 11.32 (+0.22), ISLE: 18.43 (-0.26), BLIN: 1.10 (-0.05), CCRN: 14.02 (-0.02)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 280

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 84

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 21

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 299

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 175

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 241

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 176

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 98

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Schouw & Co.'s Share Buy-Back Strategy for 2025

Updated Category News Views 153

Overview of Schouw & Co.'s Share Buy-Back Program Schouw & Co. has launched an exciting share buy-back initiative, aiming to enhance shareholder value significantly. This program began on May 5, 2025, and is designed to repurchase shares totaling up to DKK 120 million. This investment runs until December 31, 2025, reflecting the company's commitment to its shareholders....

Continue Reading
Schneider National Plans to Reveal Q3 2024 Earnings Soon

Updated Category News Views 45

Schneider National to Report Third Quarter 2024 Earnings Schneider National, Inc. (NYSE: SNDR), a leader in transportation and logistics services, has announced that it will release its third quarter 2024 earnings report on a future date, ahead of the market opening. This announcement is significant as it highlights the company’s continued focus on financial...

Continue Reading
A Closer Look at BioAge Labs: Legal Challenges Ahead

Updated Category News Views 206

Understanding the Legal Landscape of BioAge Labs Investors in BioAge Labs, Inc. have faced new uncertainties as the clinical-stage biopharmaceutical company becomes entangled in legal challenges. As the firm moves forward in its mission to develop innovative therapies aimed at combating metabolic diseases, significant developments have emerged that every investor should...

Continue Reading
Celebrating the Fusion of Science and Cinema at Starmus 2025

Updated Category News Views 202

Fusion of Science and Cinema at Starmus Festival The Starmus Festival is a unique event that intertwines science and art, culminating in extraordinary dialogues and presentations. Recently, renowned director Christopher Nolan was awarded the prestigious Stephen Hawking Medal for Science Communication during this remarkable celebration. This accolade is not just an honor...

Continue Reading
Millicom Takes Steps to Enhance Transparency in Holdings

Updated Category News Views 82

Millicom Takes Steps to Enhance Transparency in Holdings Millicom International Cellular S.A., commonly recognized as Tigo, is making significant strides in open communication and compliance by submitting regulatory notifications regarding major shareholder holdings. This initiative reinforces their commitment to transparency and regulatory excellence in the ever-evolving...

Continue Reading